Sixty Degrees Pharmaceuticals and Tufts Medical Center Announce Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention
六十度製藥與塔夫茨醫療中心宣佈專利許可協議,以推動塔芬奎寧在巴貝斯蟲病治療和預防方面的開發。
Sixty Degrees Pharmaceuticals and Tufts Medical Center Announce Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention
六十度製藥與塔夫茨醫療中心宣佈專利許可協議,以推動塔芬奎寧在巴貝斯蟲病治療和預防方面的開發。
使用瀏覽器的分享功能,分享給你的好友吧